🌎 H&R Block Initiated, Honeywell International Upgraded, International Paper Upgraded and more...

Ratings changes for Cisco Systems, Open Text, Maplight Therapeutics, Amkor Technology, Rivian Automotive, AXT, Fermi and more...Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe. MarketBeat Daily Ratings VIEW MY PORTFOLIO JULY 28TH, 2026 Follow MarketBeat on X Follow MarketBeat on Facebook Subscribe on YouTube Trump's New Dollar Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. WATCH THE FREE BRIEFING AND SEE THE THREE STEPS TO PREPARE TODAYtc pixel Today's Top Stories 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest? BY THOMAS HUGHES | JULY 28, 2026 08:10 AM Wall Street’s quietly buying these 3 AI infrastructure plays (Ad)tc pixel BY STOCKEARNINGS Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? BY NATHAN REIFF | JULY 27, 2026 12:30 PM Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight BY THOMAS HUGHES | JULY 27, 2026 11:55 AM Buy this stock tomorrow (Ad)tc pixel BY CHAIKIN ANALYTICS AMD’s AI Bubble Could Burst Into Explosive Upside BY THOMAS HUGHES | JULY 27, 2026 10:45 AM Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case BY SAM QUIRKE | JULY 27, 2026 10:10 AM 3 Stocks To Buy As Big Tech Sells Off (And 2 To Avoid) Quick Links Analyst RatingsMy MarketBeatAccount SettingsMarketBeat All AccessStock ListsStock ScreenerCalculatorsPremium ReportsBest Stocks to Buy in July A 17-year investing experiment investigated in Dublin A 17-year investing experiment investigated in Dublin (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. WATCH THE FULL INVESTIGATION AND DECIDE FOR YOURSELFtc pixel Your Watchlist MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO Apple logo Apple Inc. (AAPL) $338.72 +1.81 (+0.54%) As of 7/28/2026 9:33 AM ET Apple (NASDAQ:AAPL) will be releasing its Q3 2026 earnings after the market closes on Thursday, July 30. (View Earnings Report) Chip stocks fall as South Korea's Kospi plunges 10% before earnings 7/28 - QZ Get Paid 10% To Let Someone Else Chase GOOGL Stock Higher 7/28 - TREFIS Should You Buy Apple Stock Before July 30? 7/28 - FOOL Klarna to Power Apple Upgrade, a New Hardware Leasing Program Offered by Apple 7/28 - YAHOO Apple Upgrade launches in the United States 7/28 - YAHOO Amazon.com logo Amazon.com, Inc. (AMZN) $230.77 -0.62 (-0.27%) As of 7/28/2026 9:33 AM ET Amazon.com (NASDAQ:AMZN) will be releasing its Q2 2026 earnings after the market closes on Thursday, July 30. (View Earnings Report) Amazon.com (AMZN) had its price target lowered by analyst Lloyd Walmsley at Mizuho (star star star blank star blank star ) from $325.00 to $320.00. They now have an "outperform" rating on the stock. This represents a 38.3% upside from the current price of $231.39. Ryanair Extends AWS AI Partnership 7/28 - YAHOO Amazon winding down several flagship AI models in strategy revamp 7/28 - SEEKINGALPHA 5 Numbers to Watch as Amazon (AMZN) Reports Q2 2026 Earnings on July 30 7/28 - TIPRANKS Amazon.com (NASDAQ:AMZN) Price Target Cut to $320.00 by Analysts at Mizuho 7/28 - MARKETBEAT Bill Ackman Is Piling In Again — Pershing Square's Newest Big Bet 7/28 - 247WALLST Alphabet logo Alphabet Inc. (GOOGL) $327.75 +1.19 (+0.36%) As of 7/28/2026 9:33 AM ET 3 Top Cloud Computing Stocks Worth Buying Before August 7/28 - ZACKS Amazon, Meta and Microsoft face skeptical investors this week after Google report sparked sell-off 7/28 - CNBC Alphabet (NASDAQ:GOOGL) Rating Increased to Strong-Buy at Phillip Securities 7/28 - MARKETBEAT What is KeyCorp's Estimate for Alphabet FY2028 Earnings? 7/28 - MARKETBEAT Will Google's $200 Billion AI Bet Pay Off? History Says It Will. 7/28 - FOOL Meta Platforms logo Meta Platforms, Inc. (META) $597.56 +3.69 (+0.62%) As of 7/28/2026 9:33 AM ET Meta Platforms (NASDAQ:META) will be releasing its Q2 2026 earnings after the market closes on Wednesday, July 29. (View Earnings Report) Meta's AWS Moment May Be Here 7/28 - SEEKINGALPHA Meta, BlackRock partner on $14 billion El Paso data center 7/28 - REUTERS The Price to Finance the AI Data Center Boom Is Rising, Just Ask Meta 7/28 - WSJ Meta Announces New Strategic Venture with BlackRock to Develop Data Center in El Paso 7/28 - PRNEWSWIRE Oak Associates Ltd. OH Has $53.40 Million Position in Meta Platforms, Inc. $META 7/28 - MARKETBEAT Microsoft logo Microsoft Corporation (MSFT) $393.60 +4.50 (+1.16%) As of 7/28/2026 9:33 AM ET Microsoft (NASDAQ:MSFT) will be releasing its Q4 2026 earnings after the market closes on Wednesday, July 29. (View Earnings Report) Microsoft stock is beaten down heading into earnings - but analysts still see big upside 7/28 - MSN Katalyst Strengthens Its Platform with the Acquisition of Layer27 7/28 - YAHOO Will this be the quarter Big Tech breaks out? 7/28 - YAHOO MSFT Class Reminder: Microsoft Investors are Reminded of the Upcoming August 11 Deadline in the Filed Securities Fraud Class Action to Recover Losses 7/28 - PRNEWSWIRE Microsoft Corporation $MSFT is Parr Mcknight Wealth Management Group LLC's 3rd Largest Position 7/28 - MARKETBEAT MANAGE YOUR WATCHLIST Analysts' Upgrades Gossamer Bio (NASDAQ:GOSS) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $1.00 price target on the stock. This represents a 273.1% upside from the current price of $0.27. Honeywell International (NASDAQ:HON) was upgraded by Bank of America Corporation from "underperform" to "neutral". They now have a $265.00 price target on the stock, up from $205.00. This represents a 6.0% upside from the current price of $250.02. International Paper (NYSE:IP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $61.00 price target on the stock, up from $51.00. This represents a 39.8% upside from the current price of $43.64. JBS (NYSE:JBS) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $18.00 price target on the stock. This represents a 28.2% upside from the current price of $14.04. Lufax (NYSE:LU) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $2.00 price target on the stock. This represents a 30.4% upside from the current price of $1.53. Richardson Electronics (NASDAQ:RELL) was upgraded by Northland Securities from "market perform" to "outperform". They now have a $24.00 price target on the stock. This represents a 24.8% upside from the current price of $19.23. VIEW MORE UPGRADES This startup built what Big Tech only promised. Secure $0.79 shares before the round closes Thursday. Powering the Future of Work. Secure $0.79 Shares by Thursday. (Ad) Hybrid work is the new norm for millions of workers, but the hardware never caught up. Two monitors at a desk. One cramped laptop screen everywhere else. A different setup every time the location changes. This company's technology turns any laptop into a virtual workspace with up to five monitors, wherever the work happens. Home office. Hotel room. 1.5M+ users already work this way, many spending 40-60 hours a week inside the platform. It makes it easier to stay focused and productive without missing a beat when context-switching. The company has real technology traction, including partnerships with Meta, Samsung, and Qualcomm. SHARES AVAILABLE AT $0.79 THROUGH THURSDAY. INVEST TODAY.tc pixel Analysts' Downgrades Bank of Marin Bancorp (NASDAQ:BMRC) was downgraded by Brean Capital from "buy" to "neutral". They now have a $33.00 price target on the stock. This represents a 8.5% upside from the current price of $30.41. Eastern Bankshares (NASDAQ:EBC) was downgraded by Stephens from "overweight" to "equal weight". They now have a $24.00 price target on the stock. This represents a 3.5% upside from the current price of $23.18. ExxonMobil (NYSE:XOM) was downgraded by Bank of America Corporation from "buy" to "neutral". They now have a $158.00 price target on the stock. This represents a 2.6% upside from the current price of $154.00. Glaukos (NYSE:GKOS) was downgraded by UBS Group AG from "buy" to "neutral". The current price is $153.44. PROCEPT BioRobotics (NASDAQ:PRCT) was downgraded by UBS Group AG from "buy" to "neutral". They now have a $20.00 price target on the stock. This represents a 14.8% upside from the current price of $17.43. Spyre Therapeutics (NASDAQ:SYRE) was downgraded by Wolfe Research from "outperform" to "peer perform". The current price is $95.87. VIEW MORE DOWNGRADES ALERT: Drop these 5 stocks before the market opens tomorrow! ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions. SEE THE 5 STOCKS TO AVOIDtc pixel Analysts' New Coverage Becton, Dickinson and Company (NYSE:BDX) is now covered by UBS Group AG. They set a "buy" rating on the stock. The current price is $162.11. Edwards Lifesciences (NYSE:EW) is now covered by UBS Group AG. They set a "buy" rating and a $110.00 price target on the stock. This represents a 30.4% upside from the current price of $84.38. GXO Logistics (NYSE:GXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 65.9% downside from the current price of $52.85. H&R Block (NYSE:HRB) is now covered by Stephens. They set an "equal weight" rating and a $47.00 price target on the stock. This represents a 9.9% upside from the current price of $42.75. Integra LifeSciences (NASDAQ:IART) is now covered by UBS Group AG. They set a "neutral" rating and a $19.00 price target on the stock. This represents a 3.3% downside from the current price of $19.65. MiniMed Group (NASDAQ:MMED) is now covered by UBS Group AG. They set a "buy" rating and a $25.00 price target on the stock. This represents a 39.5% upside from the current price of $17.92. Rapport Therapeutics (NASDAQ:RAPP) is now covered by William Blair. They set an "outperform" rating on the stock. The current price is $43.98. Sensei Biotherapeutics (NASDAQ:FTH) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $60.00 price target on the stock. This represents a 98.8% upside from the current price of $30.19. Shoulder Innovations (NYSE:SI) is now covered by UBS Group AG. They set a "buy" rating and a $27.00 price target on the stock. This represents a 25.7% upside from the current price of $21.48. STAAR Surgical (NASDAQ:STAA) is now covered by UBS Group AG. They set a "sell" rating and a $20.00 price target on the stock. This represents a 10.9% downside from the current price of $22.45. Tenax Therapeutics (NASDAQ:TENX) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 113.4% upside from the current price of $16.40. Cooper Companies (NASDAQ:COO) is now covered by UBS Group AG. They set a "neutral" rating and a $75.00 price target on the stock. This represents a 5.2% upside from the current price of $71.30. TransMedics Group (NASDAQ:TMDX) is now covered by UBS Group AG. They set a "neutral" rating and a $80.00 price target on the stock. This represents a 8.9% upside from the current price of $73.49. VIEW MORE NEW COVERAGE GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Thank you for subscribing to MarketBeat! We empower everyday investors to make better trading decisions by providing up-to-the-minute financial information and best-in-class investment analysis. If you need assistance with your newsletter, please feel free to email our South Dakota based support team at contact@marketbeat.com. If you would like to opt out or update which newsletters you subscribe to, you may modify your mailing preferences or unsubscribe from these emails. © 2006-2026 MarketBeat Media, LLC. 345 North Reid Place, Suite 620, Sioux Falls, S.D. 57103. United States.. Just For You: A 17-year investing experiment investigated in Dublin (From Porter & Company)